Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,632.19
(
-0.61%
)
US TECH 100
23,737.60
(
-0.64%
)
Dow Jones
46,558.47
(
-0.26%
)
Brent Oil
101.58
(
0.00%
)
Bitcoin
71,827.99
(
0.86%
)
News Focus
News Focus
Post# of 257242
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122787
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 252016

Thursday, 09/12/2024 12:30:43 PM

Thursday, September 12, 2024 12:30:43 PM

Post# of 257242
Re: MRK/MRNA cancer vaccine

From the post I'm replying to:

MRNA says the FDA may consider mRNA-4147 for accelerated approval in melanoma based on the above phase-2b data when MRNA’s new manufacturing facility for this product in Marlborough, MA comes online.

Today (during MRNA's Investor Day presentation), MRNA acknowledged that FDA accelerated approval for mRNA-4147 based on phase-2 data is no longer under consideration

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now